Browsing COVID-19 Research by Author "Danjuma, Mohammed I."
Now showing items 1-4 of 4
-
Colchicine and mortality outcomes in patients with coronavirus disease (COVID-19)
Danjuma, Mohammed I.; Kaul, Ridhima; Alyaarabi, Tamader; Elsayed, Basant; Elshafei, Mohamed ( Elsevier , 2023 , Article)One of the therapeutic hallmarks of the ongoing (COVID-19) pandemic has been the different iterations of successful and sometimes unsuccessful attempts at re-purposing of drugs with pre-existing market authorization for ... -
The determination of causality of drug induced liver injury in patients with COVID-19 clinical syndrome
Naseralallah, Lina Mohammad; Aboujabal, Bodoor Abdallah; Geryo, Nejat Mohamed; Al Boinin, Aisha; Al Hattab, Fatima; Akbar, Raza; Umer, Waseem; Jabbar, Layla Abdul; Danjuma, Mohammed I.... more authors ... less authors ( Public Library of Science , 2022 , Article)Background Drug induced liver injury (DILI) is a rising morbidity amongst patients with COVID-19 clinical syndrome. The updated RUCAM causality assessment scale is validated for use in the general population, but its utility ... -
QTc evaluation in COVID-19 patients treated with chloroquine/hydroxychloroquine: A letter to the editor
Danjuma, Mohammed I.; Sinha, Urshita; Fatima, Haajra; Mohamed, Mouhand F.H.; Nathoe, Hendrik ( Wiley-Blackwell , 2020 , Other)We read with interest Monzani et al's report1 on QT pro-longation in COVID-19 patients on treatment with chloro-quine/hydroxychloroquine (CQ/HCQ). Her report highlights the therapeutic morbidities ... -
Seroconversion and safety of Covid-19 vaccines in patients with chronic liver disease and liver transplant: A systematic review
Y. Elzouki, Abdel Naser; Elshafei, Mohamed Nabil; Aziz, Afia; Elzouki, Islam; Waheed, Muhammad Aamir; Farooqui, Khalid; Azad, Aftab Mohammed; Habas, Elmukhtar; Danjuma, Mohammed I.... more authors ... less authors ( HBKU Press , 2023 , Article)Background and Aims: As part of the COVID-19 control strategy, a growing number of vaccine portfolios evolved and got fast-tracked through regulatory agencies, with a limited examination of their efficacy and safety in ...